Trading a BNTC straddle lets you take a pure volatility position on Benitec Biopharma Inc without committing to a direction. Benitec Biopharma Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate BNTC straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on BNTC profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Benitec Biopharma Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the BNTC straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the BNTC straddle is the cleanest expression of that view. Our scanner prices every BNTC straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a BNTC straddle into a catalyst or short a BNTC straddle to harvest decay, the options straddle setups that matter are all in one place.
